Coronary and Structural Interventions Ulm - Bioresorbable Vascular Scaffold

N/ACompletedNCT02162056

University of Ulm326 enrolled

Overview

To evaluate the safety, performance and efficacy of the bioresorbable vascular scaffold (BVS) system in patients with coronary artery disease

Patients with coronary artery disease receive bioabsorbable vascular scaffolds. Patients are clinically followed during a period of 10 years.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

326

Conditions

Coronary Artery Disease Ischemic Heart Disease Stable Angina Unstable Angina Acute Myocardial Infarction

Interventions

use of bioresorbable vascular scaffoldsDEVICE

Implantation of bioresorbable vascular scaffolds for coronary artery disease.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * coronary artery disease * implantation of at least one bioresorbable vascular scaffold Exclusion Criteria: * no written informed consent

Locations (1)

University of Ulm

Ulm, Germany

Outcomes

Primary Outcomes

Major Adverse Cardiac Events

Time frame: 10 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.